Mon.Mar 24, 2025

article thumbnail

Static Versus Dynamic Risk of Sudden Cardiac Death: Implications for Improvement of Prediction and Prevention

Journal of Cardiovascular Electrophysiology

ABSTRACT Sudden cardiac death (SCD) is a major public health challenge, resulting in significant loss of life each year. Effective prevention relies on identifying individuals at elevated risk; however, accurate prediction of SCD has proven difficult. The current clinical strategy relies on a static risk assessment, primarily using left ventricular ejection fraction (LVEF)<35% as a key criterion.

article thumbnail

New Insight: Exploring ENCELTO for MacTel with Rich Small, CEO of Neurotech

HCPLive

Veeral Sheth, MD, is joined by the CEO of Neurotech to discuss the historic approval of revakinagene taroretcel (ENCELTO) for macular telangiectasia type 2.

105
105
article thumbnail

Imperative Care Expands Precision Thrombectomy Portfolio

DAIC

tim.hodson Mon, 03/24/2025 - 15:48 March 24, 2025 Imperative Care, Inc. recently announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the 82 cm version of its Symphony 16F catheter. The catheter is designed to elevate care for patients with venous thrombosis, a serious condition caused by a blood clot forming in the veins of the legs or abdomen that can have a life-threatening impact if left untreated.

article thumbnail

TMS Reduces Pain, Yields Functional Improvements in Women With Fibromyalgia

HCPLive

Analgesic effects lasted up to week 8 while function improvements lasted until week 16 in a new randomized, controlled trial.

103
103
article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

article thumbnail

Rise in kidney disease underscores critical heart-kidney connection

American Heart News - Heart News

DALLAS, March 24, 2025 Globally, the rate of death from chronic kidney disease increased 24% from 1990 to 2021, according to statistics published by the American Heart Association, a global force changing the future of health for all. The rise in.

article thumbnail

Genetics and Environment Both Play a Role in Childhood Allergy Progression

HCPLive

A study found that genetics and environment both influence allergy risk, but environmental factors play a stronger role in the progression of allergic disease.

93

More Trending

article thumbnail

RSV Elevates Risk of Adverse CV Events

American College of Cardiology

In older adults, an acute respiratory syncytial virus (RSV) infection was significantly associated with an increased risk of cardiovascular events, in particular ischemic stroke and heart failure (HF) hospitalization.

article thumbnail

Understanding the Role of PPAR Agonists in PBC Care, with Aparna Goel, MD

HCPLive

Goel explains the importance of second-line therapies and describes the role PPARs play in PBC treatment, including 2 newly approved therapies.

64
article thumbnail

Different Post-CABG Meds May Help Radial Artery Graft Patency

Med Page Today

(MedPage Today) -- With radial artery (RA) grafts still underutilized in coronary artery bypass grafting (CABG) surgery, at least one barrier to this surgical approach may be addressed with medication, a pilot trial suggested. Testing the effects.

article thumbnail

Psoriasis Lesion Improvement at Week 16 Maintained to Week 52 with Bimekizumab

HCPLive

These data highlight the long-term maintenance of bimekizumab responses among individuals with psoriasis, looking at bio-nave and bio-switched patients.

64
article thumbnail

Does Intensive SBP Control Reduce CVD Mortality in Adults Aged 80+?

American College of Cardiology

In U.S. adults 80 years and older taking antihypertensive agents for systolic blood pressure (SBP), intensive SBP control is associated with a reduced risk of death from cardiovascular disease, supporting guidelines for intensive BP control.

article thumbnail

Alpha-Gal Syndrome Diagnosis Time Drops 70-Fold, But Disparities Persist

HCPLive

A new study found that the time it takes to diagnose alpha-gal syndrome has improved from 5.3 years to 28 days since 2011, but disparities remain based on education level.

article thumbnail

Outcomes and anticoagulant management for new-onset atrial fibrillation in patients with ST-elevation myocardial infarction following primary percutaneous coronary intervention: Findings from a national multicenter registry and meta-analysis

HeartRhythm

Little is known about the risk factors and prognosis of new-onset atrial fibrillation (NOAF) in patients with primary percutaneous coronary intervention (PCI).

article thumbnail

Exploring the Evolution of IOL Technology with Sumitra Khandelwal, MD

HCPLive

Khandelwal discusses advancements in intraocular lens (IOL) categories and the patient's role in choosing more innovative options.

article thumbnail

New-onset atrial fibrillation in acute coronary syndrome: To anticoagulate or not?

HeartRhythm

Atrial fibrillation (AF) confers significant morbidity and mortality in the form of embolic stroke, heart failure, cognitive decline, and recurrent hospitalizations as well as health care costs.1 This risk of stroke can be reduced with oral anticoagulation, but despite this, there exists a significant risk of residual major adverse events, highlighting the need for a more comprehensive approach.

article thumbnail

Clinical Pearls for Choosing the Right IOL with Sumitra Khandelwal, MD

HCPLive

Khandelwal shares insight and key takeaways for the optimization of intraocular lens selection in practice.

52
article thumbnail

Prevalence of Left Atrial Thrombus in Patients with Atrial Flutter in Comparison to Atrial Fibrillation

HeartRhythm

Atrial flutter (AFL) and atrial fibrillation (AF) are believed to carry the same risk of systemic thromboembolism however there is paucity of data concerning such risk in patients with AFL in comparison to AF.

article thumbnail

Challenges and Innovations in Wilson Disease, with Michael Schilsky, MD

HCPLive

Schilsky describes lingering challenges and unmet needs in Wilson disease and highlights recent innovations in monitoring and diagnosis.

article thumbnail

Transvenous extraction of quadripolar coronary sinus pacing leads

HeartRhythm

Quadripolar coronary sinus (CS) leads are commonly employed to achieve left ventricular pacing. There are limited data on extraction of these leads relative to traditional unipolar or bipolar CS pacing leads.

40
article thumbnail

Tildrakizumab Effective for Psoriasis, Yet Patients Note Specific Points of Dissatisfaction

HCPLive

In this analysis, French investigators highlight patient and clinician perspectives on 1-year use of tildrakizumab for moderate-to-severe psoriasis.

52
article thumbnail

Outcome of Septal Vascular Injury and Perforation in Left Bundle Branch Area Pacing: Evaluating Septal Integrity using an Institutional Protocol

HeartRhythm

Left bundle branch area pacing (LBBAP) involves deep septal lead deployment to capture the left bundle branch (LBB) or adjacent myocardium, which could compromise the septums structural integrity or pose injury to the septal vasculature. The potential long-term effects of these complications remain unclear.

article thumbnail

Examining the Role of Advocacy in Ophthalmology with Michael X. Repka, MD

HCPLive

Repka dives into the role of advocacy in shaping ophthalmologic policies and ensuring equitable patient care.

article thumbnail

A Dedicated Radiofrequency Microcatheter Assembly For Trans-Right Atrial Appendage Pericardial Carbon Dioxide Insufflation To Facilitate Epicardial Access

HeartRhythm

Trans-right atrial appendage (RAA) pericardial insufflation of CO2 can improve safety of percutaneous epicardial access. Dedicated device solutions for safe, effective and standardized microperforation are needed.

40
article thumbnail

Fostering Advocacy Efforts in Ophthalmology with Michael X. Repka, MD

HCPLive

Repka describes the complications of the US healthcare system and how to advance interactions in advocacy efforts.

52
article thumbnail

Identity-by-Descent Analysis Uncovering a Founder Event in a Novel Hereditary Small Vessel Cerebral Disease

Stroke Journal

Stroke, Ahead of Print. BACKGROUND:A novel genetic cerebral small vessel disease, linked to the insertion of a mobile genetic element in theCOL4A1gene has recently been identified. Notably, 8 out of the 10 families carrying this mutation were known to come from Brittany, a specific region in France, suggesting the possibility of a common ancestor and a founder effect.METHODS:Probands from each of the 10 families were analyzed with high-density SNP arrays.

Strokes 40
article thumbnail

Navigating Evolutions, Uncertainties in PBC Care, with Craig Lammert, MD

HCPLive

Lammert describes the clinical impact of having 2 new second-line PBC therapies, challenges to their uptake, and areas where more research is needed.

article thumbnail

Comparison of Local and Centrally Adjudicated Modified Rankin Scale Scores in the MOST Trial

Stroke Journal

Stroke, Ahead of Print. BACKGROUND:The modified Rankin Scale (mRS) is a key measure of functional outcomes in stroke trials. To minimize variability, structured tools like the Rankin Focused Assessment and central adjudication are recommended. This study compares local versus centrally adjudicated mRS scores in the MOST trial (Multi-Arm Optimization of Stroke Thrombolysis).METHODS:MOST was a phase 3, single-blind, randomized trial evaluating argatroban, eptifibatide, or placebo in addition to in

article thumbnail

Rapid Efficacy and Safety Considerations With the Use of JAK Inhibitors in Atopic Dermatitis Care

HCPLive

Panelists discuss how Janus kinase (JAK) inhibitors such as upadacitinib, abrocitinib, and baricitinib offer rapid, oral treatment for moderate to severe atopic dermatitis, differing from injectable biologics in administration, broader immunosuppression, and risk of adverse events like thromboembolism. They provide effective symptom control but require safety monitoring.

52
article thumbnail

Utility of 3D Intracardiac Echocardiography in TriClip: A Future Without Transesophageal Echocardiography?

Circulation: Cardiovascular Imaging

Circulation: Cardiovascular Imaging, Ahead of Print.

article thumbnail

Safety Protocols With JAK Inhibitors

HCPLive

Panelists discuss how the Measure Up 1 and 2 studies (Simpson 2022) showed that at 52 weeks, 82.0% to 84.9% of upadacitinib patients achieved EASI-75. Common adverse effects (AEs) included acne, cough, and headache, with 4.5% to 7.2% withdrawal rates.

52
article thumbnail

Determinants and Prognostic Value of Early Gadolinium Enhancement-Derived Myocardial Salvage Index in STEMI

Circulation: Cardiovascular Imaging

Circulation: Cardiovascular Imaging, Ahead of Print. BACKGROUND:T2-weighted imaging is commonly used to measure myocardial salvage in reperfused myocardial infarction but is hindered by poor reproducibility and indistinct boundaries. Early gadolinium enhancement (EGE) emerges as an alternative for measuring the area at risk. This study aims to evaluate the determinants of the myocardial salvage index (MSI) derived from EGE and its prognostic implications.METHODS:We analyzed acute cardiac magneti

article thumbnail

Improving Cardiovascular Health Through the Consideration of Social Factors in Genetics and Genomics Research: A Scientific Statement From the American Heart Association

Circulation: Cardiovascular Quality & Outcomes

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. Cardiovascular health (CVH) is affected by genetic, social, and genomic factors across the life course, yet little research has focused on the interrelationships among them. An extensive body of work has documented the impact of social determinants of health at both the structural and individual levels on CVH, highlighting pathways in which racism, housing, violence, and neighborhood environments adversely affect CVH and contribut

article thumbnail

Antispasmodic Medications to Optimize Long-Term Radial Artery Graft Patency in CABG

Circulation: Cardiovascular Interventions

Circulation: Cardiovascular Interventions, Ahead of Print.

article thumbnail

FDA Update: Bard Peripheral Vascular Updates Use Instructions For Rotarex Atherectomy Systems

American College of Cardiology

The U.S. Food and Drug Administration (FDA) has announced on March 20 that Bard Peripheral Vascular updated its instructions for use for Rotarex Atherectomy Systems after receiving reports of helix fracture or breakage.

Article 40
article thumbnail

How to Improve Radiation Protection in Interventional Cardiology Procedures

Circulation: Cardiovascular Interventions

Circulation: Cardiovascular Interventions, Ahead of Print. The use of ionizing radiation during cardiac catheterization procedures poses risks to patients and medical staff, both directly and indirectly through orthopedic injuries caused by lead aprons. In this review, we summarize recent advances in radiation protection in the cardiac catheterization laboratory and discuss the effectiveness of traditional and novel radiation protection strategies and equipment.

article thumbnail

ACC.25 Science Published Across JACC Journals

American College of Cardiology

The following science will be presented at ACC.25 in Chicago, IL, and was simultaneously published in JACC, JACC: CardioOncology, JACC: Heart Failure, JACC: Advances and JACC: Case Reports.